Wealth Enhancement Advisory Providers LLC lowered its stake in shares of GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report) by 45.3% in the course of the third quarter, in line with its most up-to-date 13F submitting with the SEC. The institutional investor owned 30,451 shares of the corporate’s inventory after promoting 25,237 shares in the course of the interval. Wealth Enhancement Advisory Providers LLC’s holdings in GE HealthCare Applied sciences have been value $2,858,000 on the finish of the latest reporting interval.
Different institutional buyers and hedge funds have additionally made adjustments to their positions within the firm. Pathway Monetary Advisers LLC acquired a brand new place in GE HealthCare Applied sciences in the course of the first quarter value about $25,000. BNP Paribas acquired a brand new stake in shares of GE HealthCare Applied sciences within the 1st quarter value roughly $30,000. Fred Alger Administration LLC bought a brand new place in GE HealthCare Applied sciences within the 2nd quarter valued at roughly $26,000. M&R Capital Administration Inc. acquired a brand new place in GE HealthCare Applied sciences in the course of the third quarter value $33,000. Lastly, Elkhorn Companions Restricted Partnership bought a brand new stake in GE HealthCare Applied sciences in the course of the second quarter value $31,000. 82.06% of the inventory is owned by institutional buyers and hedge funds.
Insider Exercise
In associated information, CEO Thomas J. Westrick offered 2,750 shares of the agency’s inventory in a transaction that occurred on Wednesday, August seventh. The shares have been offered at a mean worth of $80.78, for a complete worth of $222,145.00. Following the transaction, the chief govt officer now owns 17,509 shares within the firm, valued at roughly $1,414,377.02. This commerce represents a 0.00 % lower of their possession of the inventory. The transaction was disclosed in a submitting with the SEC, which is accessible by means of the SEC web site. Company insiders personal 0.27% of the corporate’s inventory.
Analyst Rankings Modifications
A number of analysis corporations have just lately issued experiences on GEHC. JPMorgan Chase & Co. initiated protection on GE HealthCare Applied sciences in a analysis notice on Monday, September ninth. They set a “impartial” score and a $90.00 worth goal for the corporate. Redburn Atlantic upgraded shares of GE HealthCare Applied sciences to a “strong-buy” score in a analysis report on Thursday, August 1st. Stifel Nicolaus upped their worth goal on shares of GE HealthCare Applied sciences from $100.00 to $102.00 and gave the corporate a “purchase” score in a report on Monday, September thirtieth. Evercore ISI raised their worth goal on shares of GE HealthCare Applied sciences from $98.00 to $102.00 and gave the inventory an “outperform” score in a analysis notice on Tuesday, October 1st. Lastly, Wells Fargo & Firm upped their goal worth on GE HealthCare Applied sciences from $95.00 to $96.00 and gave the corporate an “obese” score in a analysis notice on Thursday. One analyst has rated the inventory with a promote score, 5 have assigned a maintain score, eight have given a purchase score and one has given a powerful purchase score to the corporate’s inventory. In keeping with MarketBeat.com, the corporate presently has a consensus score of “Average Purchase” and a mean worth goal of $94.36.
Test Out Our Newest Inventory Report on GE HealthCare Applied sciences
GE HealthCare Applied sciences Inventory Efficiency
GE HealthCare Applied sciences inventory opened at $86.95 on Friday. The inventory has a fifty day transferring common worth of $88.61 and a 200 day transferring common worth of $83.45. GE HealthCare Applied sciences Inc. has a 52 week low of $66.39 and a 52 week excessive of $94.55. The agency has a market capitalization of $39.71 billion, a P/E ratio of 23.89, a PEG ratio of three.26 and a beta of 1.18. The corporate has a present ratio of 1.23, a fast ratio of 0.82 and a debt-to-equity ratio of 1.12.
GE HealthCare Applied sciences (NASDAQ:GEHC – Get Free Report) final posted its quarterly earnings information on Wednesday, October thirtieth. The corporate reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Applied sciences had a internet margin of 8.56% and a return on fairness of 25.19%. The corporate had income of $4.86 billion in the course of the quarter, in comparison with the consensus estimate of $4.87 billion. Throughout the identical quarter within the prior yr, the corporate posted $0.99 EPS. The corporate’s quarterly income was up .9% in comparison with the identical quarter final yr. Equities analysis analysts anticipate that GE HealthCare Applied sciences Inc. will put up 4.26 earnings per share for the present yr.
GE HealthCare Applied sciences Dividend Announcement
The corporate additionally just lately introduced a quarterly dividend, which will probably be paid on Friday, November fifteenth. Buyers of report on Friday, October 18th will probably be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized foundation and a yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Applied sciences’s payout ratio is presently 3.30%.
About GE HealthCare Applied sciences
GE HealthCare Applied sciences Inc engages within the growth, manufacture, and advertising of merchandise, companies, and complementary digital options used within the prognosis, therapy, and monitoring of sufferers in the US, Canada, and internationally. The corporate operates by means of 4 segments: Imaging, Ultrasound, Affected person Care Options, and Pharmaceutical Diagnostics.
See Additionally
Obtain Information & Rankings for GE HealthCare Applied sciences Each day – Enter your e-mail handle under to obtain a concise every day abstract of the most recent information and analysts’ scores for GE HealthCare Applied sciences and associated corporations with MarketBeat.com’s FREE every day e-mail publication.
